Waltham, MA, United States of America

Lawrence MacPherson

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2007-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence MacPherson. Retrieved from https://idiyas.com/inventor/lawrence-macpherson-noq387gy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Lawrence MacPherson

Introduction

Lawrence MacPherson is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical use. With a total of 2 patents, his work focuses on innovative solutions for treating infections.

Latest Patents

One of MacPherson's latest patents is titled "Fused heterocycles as inhibitors of glutamate racemase (MURI)." This invention relates to novel compounds represented by specific formulas and their pharmaceutical compositions. These compounds are designed to provide treatment or prophylaxis against infections. Another patent involves compounds with a general formula and their use in pharmaceutical compositions for similar therapeutic purposes.

Career Highlights

Lawrence MacPherson is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

MacPherson has collaborated with notable colleagues, including Marshall Morningstar and Gregory Steven Basarab. These partnerships have enhanced the scope and impact of his research efforts.

Conclusion

Lawrence MacPherson's innovative work in pharmaceuticals demonstrates his commitment to advancing medical treatments. His patents reflect a dedication to addressing critical health challenges through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…